Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up.

Paulley J W, Hughes J P. Giant cell arteritis, or arteritis of the aged. Br Med J 1960; ii: 1562-7.

Huston K A, Hunder G G, Lie J T, Kennedy R H, Elveback L R. Temporal arteritis. A 25 year epidemiological, clinical and pathologic study. Ann Intern Med 1978; 88: 162-7.

Chuang T-Y, Hunder G G, Ilstrup D M, Kurland L T. Polymyalgia rheumatica. A 10 year epidemiological and clinical study. Ann Intern Med 1982; 97: 672-80.

Ellis M E, Ralston S. ESR in the diagnosis and management of polymyalgia rheumatica/giant cell arteritis syndrome. Ann Rheum Dis 1973; 42: 168-70.

Whitfield A G W, Bateman M, Cooke W T. Temporal arteritis. Br J Ophthalmol 1963; 47: 555-66.

Rynes R I, Mika P, Bartholomew L E. Development of acute temporal arteritis in patients 'adequately' treated for polymyalgia rheumatica. Ann Rheum Dis 1977; 36: 88-90.

Malmvall B E, Bengtsson B A. GCA. Clinical features and involvement of different organs. Scand J Rheumatol 1978; 7: 154-8.

Dare B, Byrne E. Giant cell arteritis. A five year review of biopsy-proven cases in a teaching hospital. Med J Aust 1980; 1: 372-3.

Mallya R K, Berry H, Mace B E W, de Beer F C, Pepys M B. Diurnal variation of erythrocyte sedimentation rate related to feeding. Lancet 1982; i: 389-90.

Boyd R V, Hoffbrand B I. Erythrocyte sedimentation rate in elderly hospital in-patients. Br Med J 1966; i: 901-2.

Hayes G S, Stinson L N. ESR and age. Arch Ophthalmol 1970; 94: 939-40.

Bottiger L E, Svedberg C A. Normal erythrocyte sedimentation rate and age. Br Med J 1967; ii: 85-7.

Eshagian J, Goeken J A. C-reactive protein in giant cell (cranial, temporal) arteritis. Ophthalmology 1980; 87: 1160-6.

Mallya R K, Hind C R K, Berry H, Pepys M B. Serum Creactive protein in polymyalgia rheumatica: a prospective serial study. Arthritis Rheum 1985; 28: 383-7.

Park J R, Jones J G, Hazleman B L. Relationship of the erythrocyte sedimentation rate to acute phase proteins in polymyalgia rheumatica and giant cell arteritis. Ann Rheum Dis 1981; 40: 493-5.

Paolaggi J B, Chaouat D, Auquier L. An additional test for the diagnosis and monitoring of giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum 1985; 28: 837-8.

Hickling P, Dixon J S, Bird H A, Young J D, Burton H, Wright V. Acute phase reactants as predictors of the success of steroid withdrawal in polymyalgia rheumatica [Abstract]. Br J Rheumatol 1986; 25: 98.

Jones J G, Hazleman B L. Prognosis and management of polymyalgia rheumatica. Ann Rheum Dis 1981; 40: 1-5.

Paulsen S, Iversen T 0. Rheumatic polymyalgia. Long term treatment with steroids. Acta Rheumatologica Scandinavica 1971; 17: 165-8.